Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Nausea × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Intractable 1 Neoplasms 1 Nausea 1 Dyspnea 1 Delirium 1 Death 1

Interventions

Ondansetron 2 casopitant 1 Vincristine 1 Tropisetron 1 Therapeutics 1 Rituximab 1 R-CHOP protocol 1 Psychiatric Rehabilitation 1 Prochlorperazine 1 Prednisolone 1 Palonosetron 1 Midazolam 1 Metoclopramide 1 Lorazepam 1 Granisetron 1 Exercise 1 Doxorubicin 1 Dexmedetomidine 1 Dexamethasone 1 Cyclophosphamide 1 Aprepitant 1 Antiemetics 1 Acupuncture Points 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡